发明名称 |
Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent |
摘要 |
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid. |
申请公布号 |
US2015031718(A1) |
申请公布日期 |
2015.01.29 |
申请号 |
US201414470662 |
申请日期 |
2014.08.27 |
申请人 |
Purdue Pharma L.P. ;The P.F. Laboratories, Inc. ;Purdue Pharmaceuticals L.P. |
发明人 |
Wright Curtis;Oshlack Benjamin;Breder Christopher |
分类号 |
A61K47/38;A61K47/10;A61K31/485 |
主分类号 |
A61K47/38 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
Stamford CT US |